Influence of Oxidatively Modified LDL on Monocyte-macrophage Differentiation

Overview

Journal Mol Cell Biochem

Publisher Springer

Specialty Biochemistry

Date 2007 Jul 31

PMID 17660956

Citations 22

Authors

Achuthan Radhika

Shiney S Jacob

Perumana R Sudhakaran

Affiliations

Soon will be listed here.

Abstract

Transendothelial migration of peripheral blood mononuclear cells (PBMCs) and their subsequent interaction with the subendothelial matrix lead to their differentiation to macrophages (mphis). To study whether preexposure of monocytes in circulation to modified proteins influences their differentiation to mphis, an in vitro model system using isolated PBMC in culture was used. The effect of modified proteins such as oxidatively modified LDL (ox-LDL), acetylated and non-enzymatically glycated-BSA (NEG-BSA) on the differentiation process was studied by monitoring the upregulation of mphi specific functions such as endocytosis, production of matrix metalloproteinases (MMPs), expression of surface antigen, activity of beta-glucuronidase and down regulation of monocyte specific myeloperoxidase activity. Rate of endocytosis, production of MMPs and beta-glucuronidase activity were significantly greater in cells treated with modified proteins irrespective of the nature of modification. Both CuSO4 ox-LDL and HOCl ox-LDL increased the rate of expression of the mphi specific functions. FACS analysis showed that the rate of upregulation of mphi specific CD71 and down regulation of monocyte specific CD14 were high in cells supplemented with modified proteins. Studies using PPARgamma antagonist and agonist suggest its involvement in CuSO4 ox-LDL induced monocyte-macrophage (mo-mphi) differentiation whereas the expression of macrophage specific functions in cells exposed to other modified proteins was independent of PPARgamma. PBMC isolated from hypercholesterolemic rabbits in culture expressed mphi specific functions at a faster rate compared to normal controls indicating that these observations are relevant in vivo. These results indicate that preexposure of monocytes to modified proteins promote their differentiation to mphis and may serve as a feed forward type control for clearing modified proteins.

Citing Articles

Macrophages in Atherosclerosis, First or Second Row Players?.

Checkouri E, Blanchard V, Meilhac O Biomedicines. 2021; 9(9).

PMID: 34572399 PMC: 8465019. DOI: 10.3390/biomedicines9091214.

Sulfated polysaccharide ascophyllan from Padina tetrastromatica enhances healing of burn wounds by ameliorating inflammatory responses and oxidative damage.

Sulaiman M, Alyileili S, Raghavankutty M, Kurup G Mol Biol Rep. 2020; 47(11):8701-8710.

PMID: 33130964 DOI: 10.1007/s11033-020-05914-5.

Decreased expression of FcγRII in active Graves' disease patients.

Lu X, Peng S, Wang X, Shan Z, Teng W J Clin Lab Anal. 2019; 33(6):e22904.

PMID: 31033004 PMC: 6642309. DOI: 10.1002/jcla.22904.

Scientific validation of anti-arthritic effect of Kashayams - A polyherbal formulation in collagen induced arthritic rats.

I S A, Krishnan S, Peter J, Sabu V, Helen A J Ayurveda Integr Med. 2019; 12(1):20-27.

PMID: 30660454 PMC: 8039352. DOI: 10.1016/j.jaim.2018.02.139.

Antioxidants in the Fight Against Atherosclerosis: Is This a Dead End?.

Toledo-Ibelles P, Mas-Oliva J Curr Atheroscler Rep. 2018; 20(7):36.

PMID: 29781062 PMC: 5960648. DOI: 10.1007/s11883-018-0737-7.

References

Jacob S, Shastry P, Sudhakaran P . Monocyte-macrophage differentiation in vitro: modulation by extracellular matrix protein substratum. Mol Cell Biochem. 2002; 233(1-2):9-17. DOI: 10.1023/a:1015593232347. View

Ramprasad M, Terpstra V, Kondratenko N, Quehenberger O, Steinberg D . Cell surface expression of mouse macrosialin and human CD68 and their role as macrophage receptors for oxidized low density lipoprotein. Proc Natl Acad Sci U S A. 1996; 93(25):14833-8. PMC: 26222. DOI: 10.1073/pnas.93.25.14833. View

Sudhakaran P, Radhika A, Jacob S . Monocyte macrophage differentiation in vitro: Fibronectin-dependent upregulation of certain macrophage-specific activities. Glycoconj J. 2006; 24(1):49-55. DOI: 10.1007/s10719-006-9011-2. View

Basu S, Goldstein J, Anderson G, Brown M . Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts. Proc Natl Acad Sci U S A. 1976; 73(9):3178-82. PMC: 430973. DOI: 10.1073/pnas.73.9.3178. View

Tabas I . Nonoxidative modifications of lipoproteins in atherogenesis. Annu Rev Nutr. 1999; 19:123-39. DOI: 10.1146/annurev.nutr.19.1.123. View

Jacob S, Shastry P, Sudhakaran P . Influence of non-enzymatically glycated collagen on monocyte-macrophage differentiation. Atherosclerosis. 2001; 159(2):333-41. DOI: 10.1016/s0021-9150(01)00521-4. View

Stanton L, WHITE R, Bryant C, Protter A, Endemann G . A macrophage Fc receptor for IgG is also a receptor for oxidized low density lipoprotein. J Biol Chem. 1992; 267(31):22446-51. View

Endemann G, Stanton L, Madden K, Bryant C, WHITE R, Protter A . CD36 is a receptor for oxidized low density lipoprotein. J Biol Chem. 1993; 268(16):11811-6. View

Malden L, Chait A, Raines E, Ross R . The influence of oxidatively modified low density lipoproteins on expression of platelet-derived growth factor by human monocyte-derived macrophages. J Biol Chem. 1991; 266(21):13901-7. View

10.

Itabe H, Mori M, Fujimoto Y, Higashi Y, Takano T . Minimally modified LDL is an oxidized LDL enriched with oxidized phosphatidylcholines. J Biochem. 2003; 134(3):459-65. DOI: 10.1093/jb/mvg164. View

11.

Williams K, Tabas I . The response-to-retention hypothesis of early atherogenesis. Arterioscler Thromb Vasc Biol. 1995; 15(5):551-61. PMC: 2924812. DOI: 10.1161/01.atv.15.5.551. View

12.

Forman B, Tontonoz P, Chen J, Brun R, Spiegelman B, Evans R . 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell. 1995; 83(5):803-12. DOI: 10.1016/0092-8674(95)90193-0. View

13.

Galis Z, Sukhova G, Lark M, Libby P . Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest. 1994; 94(6):2493-503. PMC: 330083. DOI: 10.1172/JCI117619. View

14.

Nathan C, Murray H, COHN Z . The macrophage as an effector cell. N Engl J Med. 1980; 303(11):622-6. DOI: 10.1056/NEJM198009113031106. View

15.

Nagy L, Tontonoz P, Alvarez J, Chen H, Evans R . Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma. Cell. 1998; 93(2):229-40. DOI: 10.1016/s0092-8674(00)81574-3. View

16.

Westendorf T, Graessler J, Kopprasch S . Hypochlorite-oxidized low-density lipoprotein upregulates CD36 and PPARgamma mRNA expression and modulates SR-BI gene expression in murine macrophages. Mol Cell Biochem. 2005; 277(1-2):143-52. DOI: 10.1007/s11010-005-5873-z. View

17.

Xu X, Meisel S, Ong J, Kaul S, Cercek B, Rajavashisth T . Oxidized low-density lipoprotein regulates matrix metalloproteinase-9 and its tissue inhibitor in human monocyte-derived macrophages. Circulation. 1999; 99(8):993-8. DOI: 10.1161/01.cir.99.8.993. View

18.

Hayden J, Brachova L, Higgins K, Obermiller L, Sevanian A, Khandrika S . Induction of monocyte differentiation and foam cell formation in vitro by 7-ketocholesterol. J Lipid Res. 2002; 43(1):26-35. View

19.

Fong L, Fong T, Cooper A . Inhibition of lipopolysaccharide-induced interleukin-1 beta mRNA expression in mouse macrophages by oxidized low density lipoprotein. J Lipid Res. 1991; 32(12):1899-910. View

20.

Glass C, Witztum J . Atherosclerosis. the road ahead. Cell. 2001; 104(4):503-16. DOI: 10.1016/s0092-8674(01)00238-0. View